https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_RETIKUS_tg-1030x427-1.jpg
427
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-18 15:07:222025-03-20 10:32:03US President deprioritises biotechnology
https://european-biotechnology.net/wp-content/uploads/2025/03/Sofinnova-partners_-DARIKA-1000_F_923962143_9P76yptBiAx0RlqF5Lxm7JJClXeuOjws.jpg
560
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-18 09:28:012025-03-18 09:28:01Sofinnova Partners closes €165m Biovelocita II biotech acceleration fund
https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_Insight_Czeslaw-Siekierski_tg-1030x435-1.jpeg
435
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-17 10:27:522025-03-17 10:27:52Poland breaks opposition to EU NGT deregulation
https://european-biotechnology.net/wp-content/uploads/2025/03/SpliceBio-1030x465-1.jpg
465
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-14 09:32:332025-03-14 09:32:33SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease
https://european-biotechnology.net/wp-content/uploads/2025/03/FSA-1030x719-1.jpeg
719
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 11:50:152025-03-12 11:50:15Regulatory sandbox will speed up safety assessment of cell-based food
https://european-biotechnology.net/wp-content/uploads/2025/03/1000_F_1033449356_saD0ccutRtdFMXmfjDrcG2LSXgAG18TI.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 08:43:192025-03-12 08:43:19Roche inks US$1.65bn obesity deal with Zealand Pharma
https://european-biotechnology.net/wp-content/uploads/2025/03/Novo-Logo.jpg
562
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-10 20:21:492025-03-10 20:21:49Novo Nordisk’s obesity drug CagriSema disappoints again
https://european-biotechnology.net/wp-content/uploads/2025/03/Roche-xpandomer-synthesis-4x-1030x266-1.png
266
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 10:55:442025-03-04 10:55:44Roche unveils completely new sequencing approach
https://european-biotechnology.net/wp-content/uploads/2025/03/Hummingbird-2.png
944
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 09:30:182025-03-04 09:30:18ADC maker Callio Therapeutics secures US$187m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/02/Cean-industrial-deal-press-conference-26-feb-2025-e1740653248529-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-27 10:49:112025-02-27 10:49:11EU Commission presents Clean Industrial Deal
Scroll to top
